Bio-C8, 3 µm - Reversed Phase

Cat. No.	Description	Specification	Unit	Price
CC02501768-01	Guard Column	Bio-C8 (3 µm, 300 Å), 4.6×50mm	Each	Inquiry
CC02501768-02		Bio-C8 (3 µm, 300 Å), 4.6×150mm	Each	Inquiry
CC02501768-03		Bio-C8 (3 µm, 300 Å), 4.6×250mm	Each	Inquiry
CC02501768-04	Custom Column, Guard Cartridge only	Bio-C8 (3 µm, 300 Å), 2.0×10mm	Each	Inquiry
CC02501768-05	Custom Column, Guard Cartridge with holder	Bio-C8 (3 µm, 300 Å), 2.0×10mm	Each	Inquiry
CC02501768-06	Custom Column	Bio-C8 (3 µm, 300 Å), 2.1×30mm	Each	Inquiry
CC02501768-07	Custom Column, Guard Column	Bio-C8 (3 µm, 300 Å), 2.1×50mm	Each	Inquiry
CC02501768-08	Custom Column	Bio-C8 (3 µm, 300 Å), 2.1×150mm	Each	Inquiry
CC02501768-09	Custom Column	Bio-C8 (3 µm, 300 Å), 2.1×250mm	Each	Inquiry
CC02501768-10	Custom Column, Guard Cartridge only	Bio-C8 (3 µm, 300 Å), 4.0×10mm	Each	Inquiry
CC02501768-11	Custom Column, Guard Cartridge with holder	Bio-C8 (3 µm, 300 Å), 4.0×10mm	Each	Inquiry

Product Description

Product Description

Bio-C8 phase is made of monomeric and fully endcapped chemistry. The uniform stationary phase allows the separation to achieve high selectivity and high efficiency. Bio-C8 packings of 300 Å pore size selection are ideal for high resolution mapping of peptides and separation of natural and synthetic peptides and small proteins.

Features

• Highly controlled chemistry of monolayer formation and end-capping
• Extremely high column-to-column reproducibility
• High selectivity and efficiency for separations
• Full coverage bonded silica packing to achieve the exceptionally high stability
• Suitable for separations of acidic, neutral and basic organic compounds, such as pharmaceuticals, peptides, and organic acids

Specifications

Silica: Sperical, high purity (<10 ppm metals)
Pore size: 300Å
Particle size: 3, 5 and 10 µm
Pore volume: 0.9 ml/g
Surface area: 105 m²/g
Phase structure: Monomeric and fully endcapped
% Carbon: 4.0%